Darin J.  Weber net worth and biography

Darin Weber Biography and Net Worth

Insider of ProKidney

Dr. Weber joined ProKidney as Senior Vice President of Regulatory Development in September 2020, and was promoted to Chief Regulatory Officer, SVP and Head of Global Regulatory Affairs, Quality Management, Biometrics and Market Access. He is responsible for leading the development and implementation of ProKidney’s regulatory strategy in all markets, worldwide, interfacing with regulatory authorities and oversight of quality management, market access, pricing and reimbursement. Dr. Weber has over 25 years of experience in cellular and tissue-based regenerative medicine products, with previous roles as Senior Vice President of Regulatory and Quality at Medeor Therapeutics, from February 2016 to December 2019; Executive Vice President of Global Regulatory Affairs and Quality Management at Mesoblast, from June 2011 to February 2016; Senior Consultant for Cell and Gene Therapies at Biologics Consulting Group from February 2004 to May 2011, and positions of increasing responsibility at the FDA’s Center for Biologics Evaluation and Research, including as Chief of Cellular Therapies Branch in the Office of Cellular, Tissues and Gene Therapies, (now known as the Office of Tissues and Advanced Therapies) from September 1996 to January 2004. He is a long-serving member of United States Pharmacopeia (USP) expert committees for human tissues and advanced therapies. Dr. Weber received his B.S. in Molecular Biology from The Evergreen State College and a Ph.D. in Biochemistry and Biophysics from Oregon State University.

What is Darin J. Weber's net worth?

The estimated net worth of Darin J. Weber is at least $265.94 thousand as of September 19th, 2024. Weber owns 103,480 shares of ProKidney stock worth more than $265,944 as of December 5th. This net worth evaluation does not reflect any other assets that Weber may own. Learn More about Darin J. Weber's net worth.

How old is Darin J. Weber?

Weber is currently 56 years old. There are 4 older executives and no younger executives at ProKidney. The oldest executive at ProKidney is Dr. Timothy A. Bertram D.V.M., Ph.D., Founder, who is 69 years old. Learn More on Darin J. Weber's age.

How do I contact Darin J. Weber?

The corporate mailing address for Weber and other ProKidney executives is 2850 W. HORIZON RIDGE PARKWAY SUITE 200, HENDERSON NV, 89052. ProKidney can also be reached via phone at 336-999-7028 and via email at [email protected]. Learn More on Darin J. Weber's contact information.

Has Darin J. Weber been buying or selling shares of ProKidney?

Darin J. Weber has not been actively trading shares of ProKidney in the last ninety days. Most recently, Darin J. Weber sold 103,480 shares of the business's stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $3.02, for a transaction totalling $312,509.60. Learn More on Darin J. Weber's trading history.

Who are ProKidney's active insiders?

ProKidney's insider roster includes Pablo Legorreta (Director), and Darin Weber (Insider). Learn More on ProKidney's active insiders.

Are insiders buying or selling shares of ProKidney?

In the last year, ProKidney insiders bought shares 4 times. They purchased a total of 1,787,716 shares worth more than $1,175,418.66. In the last year, insiders at the sold shares 3 times. They sold a total of 860,642 shares worth more than $2,196,242.64. The most recent insider tranaction occured on November, 13th when Director Brian Jg Pereira sold 502,136 shares worth more than $1,190,062.32. Insiders at ProKidney own 41.5% of the company. Learn More about insider trades at ProKidney.

Information on this page was last updated on 11/13/2025.

Darin J. Weber Insider Trading History at ProKidney

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/8/2025Sell103,480$3.02$312,509.60View SEC Filing Icon  
9/19/2024Sell16,412$2.50$41,030.00103,480View SEC Filing Icon  
7/26/2024Sell826$2.50$2,065.00119,892View SEC Filing Icon  
5/20/2024Sell17,238$4.08$70,331.04137,956View SEC Filing Icon  
4/22/2024Sell16,438$2.51$41,259.38155,194View SEC Filing Icon  
4/18/2024Sell800$2.54$2,032.00171,632View SEC Filing Icon  
4/16/2024Sell17,238$2.50$43,095.00172,432View SEC Filing Icon  
4/12/2024Sell84,103$1.73$145,498.19189,670View SEC Filing Icon  
4/1/2024Sell300$1.69$507.00273,773View SEC Filing Icon  
See Full Table

Darin J. Weber Buying and Selling Activity at ProKidney

This chart shows Darin J Weber's buying and selling at ProKidney by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ProKidney Company Overview

ProKidney logo
ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Read More

Today's Range

Now: $2.57
Low: $2.41
High: $2.59

50 Day Range

MA: $2.72
Low: $2.09
High: $3.30

2 Week Range

Now: $2.57
Low: $0.46
High: $7.13

Volume

1,342,076 shs

Average Volume

1,357,419 shs

Market Capitalization

$773.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79